Prestige BioPharma Limited (KRX:950210)
South Korea · Delayed Price · Currency is KRW 16,700
+160 (0.97%)
At close: Jul 16, 2025, 3:30 PM KST
Prestige BioPharma Market Cap
Prestige BioPharma has a market cap or net worth of 193.51 billion as of July 18, 2025. Its market cap has increased by 79.89% in one year.
Market Cap
193.51B
Enterprise Value
227.02B
Revenue
8.66B
Ranking
n/a
PE Ratio
44.50
Stock Price
16,700.00
Market Cap Chart
Since May 28, 2021, Prestige BioPharma's market cap has decreased from 360.58B to 193.51B, a decrease of -46.33%. That is a compound annual growth rate of -13.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 193.51B | 6.55% |
| Dec 30, 2024 | 181.61B | 59.39% |
| Dec 28, 2023 | 113.94B | 29.33% |
| Dec 29, 2022 | 88.10B | -64.84% |
| Dec 30, 2021 | 250.60B | -30.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.52T |
| Celltrion | 39.84T |
| ALTEOGEN | 26.11T |
| Yuhan | 8,429.07B |
| SK Biopharmaceuticals | 7,635.54B |
| HLB Co., Ltd. | 6,834.05B |
| PharmaResearch | 6,005.22B |
| Peptron | 5,521.47B |